For instance, the ferroptosis inducer erastin has been found to inhibit the degradation of NRF2 by modulating the p62‐Keap1‐NRF2 signalling pathway, thereby suppressing ferroptosis in hepatoma cells.33 The gene discussed is KEAP1; the disease is hepatocellular carcinoma.